Menu Search Account

LegiStorm

Get LegiStorm App Visit Product Demo Website
» Get LegiStorm App
» Get LegiStorm Pro Free Demo

Senate committees schedule archive

04/05/22 2:30 PM

Location : SH-219
To receive a closed briefing on certain intelligence matters.

Location : SVC-217
Closed hearings to examine training the next generation of cyber operators.

04/05/22 11:00 AM

Location : SD-608
Hearings to examine corporate profits and rising prices.

04/05/22 10:00 AM

Location : SD-538
Hearings to examine insider trading legislation, focusing on fair markets, including S.3990, to amend the Securities Exchange Act of 1934 to prohibit certain securities trading and related communications by those who possess material, nonpublic information, H.R.6553, to promote a 21st century artificial intelligence workforce, S.3730, to ensure a complete analysis of the potential impacts of rules on small entities, S.3980, to require the Securities and Exchange Commission to carry out a study of the costs associated with small- and medium-sized companies to undertake initial public offerings, S.3919, to amend the Securities Exchange Act of 1934 to provide that an issuer that is required to file certain quarterly reports may elect to file those reports semiannually, S.3923, to amend the Dodd-Frank Wall Street Reform and Consumer Protection Act to repeal certain provisions requiring non-material disclosure, S.3945, to amend the Securities Exchange Act of 1934 to address the solicitation of proxy with respect to securities, S.3097, to amend the Securities Exchange Act of 1934 to allow for the registration of venture exchanges, S.3976, to amend the Investment Company Act of 1940 to address entities that are not considered to be investment companies for the purposes of that Act, S.3914, to require the Securities and Exchange Commission to revise the definition of a qualifying investment, for purposes of the exemption from registration for venture capital fund advisers under the Investment Advisers Act of 1940, to include an equity security issued by a qualifying portfolio company and to include an investment in another venture capital fund, S.3939, to amend the Securities Act of 1933 to provide small issuers with a micro-offering exemption free of mandated disclosures or offering filings, but subject to the antifraud provisions of the Federal securities laws, S.3922, to amend the Securities Exchange Act of 1934 to create a safe harbor for finders and private placement brokers, S.3391, to amend the Securities Exchange Act of 1934 to establish a registration exemption for merger and acquisition brokers, S.3931, to require the Securities and Exchange Commission to extend exemptions for securities offered as part of employee pay to other individuals providing goods for sale, labor, or services for remuneration, S.3948, to amend the Investment Company Act of 1940 to prohibit limitations on closed-end companies investing in private funds, S.3967, to amend the Securities Act of 1933 to preempt State securities law requiring registration for secondary transactions, S.3921, to amend the Securities Act of 1933 to expand the definition of a qualifying accredited investor, S.3966, to amend the Securities Act of 1933 to define secondary offerings of Regulation A tier 2 securities as covered securities for purposes of an exemption from State regulation, S.3921, to amend the Securities Act of 1933 to expand the definition of a qualifying accredited investor, S.3631, to prohibit stock trading and ownership by Members of Congress and spouses of Members of Congress, and S.2360, to amend the Securities Exchange Act of 1934 to require the Securities and Exchange Commission to issue rules that prohibit officers and directors of certain companies from trading securities in anticipation of a current report.

Location : SD-106
Hearings to examine FDA user fee agreements, focusing on advancing medical product regulation and innovation for the benefit of patients.

Location : SR-253
Hearings to examine ensuring transparency in the petroleum markets.

Location : SD-406
Hearings to examine implementation of the Drinking Water and Wastewater Infrastructure Act, focusing on stakeholders' needs and experiences.

Location : SD-430
Hearings to examine FDA user fee agreements, focusing on advancing medical product regulation and innovation for the benefit of patients.

Location : SD-215
Hearings to examine the President's proposed budget request for fiscal year 2023 for the Department of Health and Human Services.

04/05/22 9:30 AM

Location : SD-G50
Hearings to examine the posture of United States Special Operations Command and United States Cyber Command in review of the Defense Authorization Request for fiscal year 2023 and the Future Years Defense Program; to be immediately followed by a closed session in SVC-217.

« Return to Senate committees schedule archive